CanSino Biologics, Inc. Class H(HK:6185)
HK$23.78-2.08 (-8.04%)
HK:6185
CanSino Biologics, Inc. Class H Revenue
HK$23.78
At close:-2.08 (-8.04%)
Want to see HK:6185 full AI Analyst Report?
CanSino Biologics, Inc. Class H (6185) Revenue
7 Followers
CanSino Biologics, Inc. Class H Revenue
CanSino Biologics, Inc. Class H had a revenue of 332.43M in the quarter ending Sep 30, 2026, with -7.15%. This bring the company's revenue in the last twelve months to 1.25B, Increased 1.82%. In the fiscal year ending Dec 31, 2025, CanSino Biologics, Inc. Class H had annual revenue of 1.03B with 21.93% growth.
- Revenue (ttm)
- 1.25B
- Revenue Growth
- 36.09%
- P/S Ratio
- 11.94
- Revenue/Employee
- HKD 910,031
- Employees
- 1,134
- Market Cap
- HKD 12.32B
Revenue Chart
CanSino Biologics, Inc. Class H Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.03B | 185.64M | 21.93% |
| Dec 31, 2024 | 846.34M | 501.16M | 145.19% |
| Dec 31, 2023 | 345.18M | -685.86M | -66.52% |
| Dec 31, 2022 | 1.03B | -3.27B | -76.02% |
| Dec 31, 2021 | 4.30B | 4.27B | 17174.82% |
| Dec 31, 2020 | 24.89M | 22.61M | 990.05% |
| Dec 31, 2019 | 2.28M | 1.15M | 101.71% |
| Dec 31, 2018 | 1.13M | -8.05M | -87.67% |
| Dec 31, 2017 | 9.18M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.